William Blair Downgrades Minerva Neurosciences (NERV) to Market Perform, Following Pharma Study Results
Tweet Send to a Friend
William Blair analyst Myles R. Minter downgraded Minerva Neurosciences ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
